Mekan R. Orazov, Liudmila M. Mikhaleva, Viktor E. Radzinskiy, Marina B. Khamoshina, Abecha K. Barinova, Dmitry G. Aryutin, Marina V. Tsaregorodtseva, Irina V. Besman, Vafa Yu. Ibragimova
{"title":"子宫腺肌病相关性不孕妇女体外受精失败的危险因素","authors":"Mekan R. Orazov, Liudmila M. Mikhaleva, Viktor E. Radzinskiy, Marina B. Khamoshina, Abecha K. Barinova, Dmitry G. Aryutin, Marina V. Tsaregorodtseva, Irina V. Besman, Vafa Yu. Ibragimova","doi":"10.26442/20795696.2023.3.202379","DOIUrl":null,"url":null,"abstract":"Aim. To identify risk factors for in vitro fertilization (IVF) failures in women with adenomyosis-associated infertility.
 Materials and methods. The study included 83 patients of reproductive age with adenomyosis. Women were divided into two groups: the main group (n=53) included patients with adenomyosis and a history of 1 or more unsuccessful attempts at embryo transfer, and the comparison group (n=30) included women with adenomyosis without impaired fertile function. The mean age of the patients was 364.0 years.
 Results. Gynecological conditions such as cervical dysplasia, noninflammatory vaginal diseases, and a history of sexually transmitted infections (STIs) were significantly (5-fold) more common in patients with a history of IVF failures (p0.05). A high prevalence of endocrine and digestive system disorders (27.7 and 7.7 times, respectively) was found in infertile women with adenomyosis (p0.05). Coagulation disorders were identified 4.8 times more often in women with adenomyosis-associated infertility and IVF failures. Inflammatory and proliferative endometrial diseases (hyperplasia, intrauterine synechia, and chronic endometritis) were significantly more common in patients in the main group than in patients with adenomyosis without impaired fertility (p0.05).
 Conclusion. Risk factors for IVF failure in women with adenomyosis-associated infertility are other specified coagulation defects [D68.8] (antiphospholipid syndrome), odds ratio (OR) 4.8, 95% confidence interval (CI) 1.120.9; dysplasia of cervix uteri, unspecified [N87.9] (OR 10.2, 95% CI 1.292.4), other noninflammatory disorders of vagina [N89.7] (OR 10.2, 95% CI 1.292.4), STIs (OR 12.7, 95% CI 1.4112.5), endocrine system disorders (OR 27.7, 95% CI 1.5516.5), and digestive system disorders (OR 7.8, 95% CI 2.227.8).","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk factors for in vitro fertilization failures in women with adenomyosis-associated infertility\",\"authors\":\"Mekan R. Orazov, Liudmila M. Mikhaleva, Viktor E. Radzinskiy, Marina B. Khamoshina, Abecha K. Barinova, Dmitry G. Aryutin, Marina V. Tsaregorodtseva, Irina V. Besman, Vafa Yu. Ibragimova\",\"doi\":\"10.26442/20795696.2023.3.202379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim. To identify risk factors for in vitro fertilization (IVF) failures in women with adenomyosis-associated infertility.
 Materials and methods. The study included 83 patients of reproductive age with adenomyosis. Women were divided into two groups: the main group (n=53) included patients with adenomyosis and a history of 1 or more unsuccessful attempts at embryo transfer, and the comparison group (n=30) included women with adenomyosis without impaired fertile function. The mean age of the patients was 364.0 years.
 Results. Gynecological conditions such as cervical dysplasia, noninflammatory vaginal diseases, and a history of sexually transmitted infections (STIs) were significantly (5-fold) more common in patients with a history of IVF failures (p0.05). A high prevalence of endocrine and digestive system disorders (27.7 and 7.7 times, respectively) was found in infertile women with adenomyosis (p0.05). Coagulation disorders were identified 4.8 times more often in women with adenomyosis-associated infertility and IVF failures. Inflammatory and proliferative endometrial diseases (hyperplasia, intrauterine synechia, and chronic endometritis) were significantly more common in patients in the main group than in patients with adenomyosis without impaired fertility (p0.05).
 Conclusion. Risk factors for IVF failure in women with adenomyosis-associated infertility are other specified coagulation defects [D68.8] (antiphospholipid syndrome), odds ratio (OR) 4.8, 95% confidence interval (CI) 1.120.9; dysplasia of cervix uteri, unspecified [N87.9] (OR 10.2, 95% CI 1.292.4), other noninflammatory disorders of vagina [N89.7] (OR 10.2, 95% CI 1.292.4), STIs (OR 12.7, 95% CI 1.4112.5), endocrine system disorders (OR 27.7, 95% CI 1.5516.5), and digestive system disorders (OR 7.8, 95% CI 2.227.8).\",\"PeriodicalId\":36505,\"journal\":{\"name\":\"Gynecology\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26442/20795696.2023.3.202379\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26442/20795696.2023.3.202379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
的目标。探讨子宫腺肌病相关性不孕妇女体外受精失败的危险因素。
材料和方法。该研究纳入了83例育龄腺肌病患者。将女性分为两组:主要组(n=53)包括有1次或1次以上胚胎移植失败史的子宫腺肌症患者,对照组(n=30)包括未受影响的生育功能的子宫腺肌症患者。患者平均年龄364.0岁。
结果。宫颈发育不良、非炎症性阴道疾病和性传播感染史等妇科疾病在试管婴儿失败史患者中更为常见(5倍)(p0.05)。子宫腺肌病不孕妇女的内分泌和消化系统疾病患病率较高,分别为27.7倍和7.7倍(p0.05)。在与子宫腺肌病相关的不孕和试管婴儿失败的妇女中,凝血功能障碍的发生率高出4.8倍。炎性和增殖性子宫内膜疾病(增生、宫内粘连、慢性子宫内膜炎)在主组患者中的发生率明显高于未影响生育能力的子宫腺肌病患者(p0.05)。结论。子宫腺肌病相关性不孕妇女IVF失败的危险因素是其他特定凝血缺陷[D68.8](抗磷脂综合征),优势比(OR)为4.8,95%可信区间(CI)为1.120.9;宫颈发育不良,未明确[N87.9] (OR 10.2, 95% CI 1.292.4),其他阴道非炎症性疾病[N89.7] (OR 10.2, 95% CI 1.292.4),性传播感染(OR 12.7, 95% CI 1.4112.5),内分泌系统疾病(OR 27.7, 95% CI 1.5516.5),消化系统疾病(OR 7.8, 95% CI 2.227.8)。
Risk factors for in vitro fertilization failures in women with adenomyosis-associated infertility
Aim. To identify risk factors for in vitro fertilization (IVF) failures in women with adenomyosis-associated infertility.
Materials and methods. The study included 83 patients of reproductive age with adenomyosis. Women were divided into two groups: the main group (n=53) included patients with adenomyosis and a history of 1 or more unsuccessful attempts at embryo transfer, and the comparison group (n=30) included women with adenomyosis without impaired fertile function. The mean age of the patients was 364.0 years.
Results. Gynecological conditions such as cervical dysplasia, noninflammatory vaginal diseases, and a history of sexually transmitted infections (STIs) were significantly (5-fold) more common in patients with a history of IVF failures (p0.05). A high prevalence of endocrine and digestive system disorders (27.7 and 7.7 times, respectively) was found in infertile women with adenomyosis (p0.05). Coagulation disorders were identified 4.8 times more often in women with adenomyosis-associated infertility and IVF failures. Inflammatory and proliferative endometrial diseases (hyperplasia, intrauterine synechia, and chronic endometritis) were significantly more common in patients in the main group than in patients with adenomyosis without impaired fertility (p0.05).
Conclusion. Risk factors for IVF failure in women with adenomyosis-associated infertility are other specified coagulation defects [D68.8] (antiphospholipid syndrome), odds ratio (OR) 4.8, 95% confidence interval (CI) 1.120.9; dysplasia of cervix uteri, unspecified [N87.9] (OR 10.2, 95% CI 1.292.4), other noninflammatory disorders of vagina [N89.7] (OR 10.2, 95% CI 1.292.4), STIs (OR 12.7, 95% CI 1.4112.5), endocrine system disorders (OR 27.7, 95% CI 1.5516.5), and digestive system disorders (OR 7.8, 95% CI 2.227.8).